|
| Press Releases |
|
 |
|
| Monday, June 27, 2022 |
|
|
醫思健康榮獲《機構投資者》2022亞洲區最佳管理團隊多個獎項 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然公佈集團於國際金融權威雜誌《機構投資者》發布的2022年度「亞洲區最佳管理團隊」榜單中榮獲醫療健康及製藥類別多個獎項。 more info >> |
|
|
EC Healthcare Received "Institutional Investor" 2022 Multiple Awards in All-Asia Executive Team Rankings |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* more info >> |
|
| Thursday, June 23, 2022 |
|
|
医思健康公布2021/22年度全年业绩 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）公布截至2022年3月31日止财政年度（「年内」）之经审核全年业绩。 more info >> |
|
|
醫思健康公佈2021/22年度全年業績 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）公佈截至2022年3月31日止財政年度（「年內」）之經審核全年業績。 more info >> |
|
|
EC Healthcare Announces FY2021/22 Annual Results |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its audited annual results for the fiscal year ended 31 March 2022 (the "Year").
more info >> |
|
| Tuesday, June 21, 2022 |
|
|
醫思健康訂立可持續發展表現掛鈎雙重貸款 開創香港醫療健康市場先河 |
| 香港最大非醫院醫療服務機構*──醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團首次訂立可持續發展表現掛鈎貸款（「可持續發展貸款」），總值為7億港元。 more info >> |
|
|
EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* more info >> |
|
| Monday, June 6, 2022 |
|
|
医思健康携手凯龙瑞及亚洲联合基建成立合资公司 |
| 香港最大非医院医疗服务机构*──医思健康（「公司」，连同附属公司，统称「集团」；香港联交所股份编号：2138）欣然宣布，集团与房地产投资管理公司凯龙瑞集团（「凯龙瑞」）及亚洲联合基建控股有限公司（「亚洲联合基建」；香港联交所股份编号：0711）成立合资公司（「合资公司」） more info >> |
|
|
醫思健康攜手凱龍瑞及亞洲聯合基建成立合資公司 |
| 香港最大非醫院醫療服務機構*──醫思健康（「公司」，連同附屬公司，統稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團與房地產投資管理公司凱龍瑞集團（「凱龍瑞」）及亞洲聯合基建控股有限公司（「亞洲聯合基建」；香港聯交所股份編號：0711）成立合資公司（「合資公司」） more info >> |
|
|
EC Healthcare Forms a Joint Venture with KaiLong and Asia Allied Infrastructure |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group formed a joint venture company (the "JV Company") with a real estate investment management company more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
"Ashes of the Kingdom" Breaks Barriers to Captivate the World: Chinese Female-Oriented Games Showcase Global Impact
Sept 11, 2024 23:00 HKT/SGT
|
|
|
Pixotope Forges Strategic Partnership with Happy Elephant Consortium for Asia-Pacific Expansion
Sept 11, 2024 21:00: JST
|
|
|
Pixotope與Happy Elephant Consortium達成戰略合作夥伴關係，推動亞太地區擴展
Sept 11, 2024 20:00 HKT/SGT
|
|
|
Pixotope与Happy Elephant Consortium达成战略合作伙伴关系，推动亚太地区扩展
Sept 11, 2024 20:00 HKT/SGT
|
|
|
Pixotope Forges Strategic Partnership with Happy Elephant Consortium for Asia-Pacific Expansion
Sept 11, 2024 20:00 HKT/SGT
|
|
|
Sculpting Reimagined: Maxon Releases ZBrush for iPad
Sept 11, 2024 20:00 HKT/SGT
|
|
|
Belt and Road Summit Opened Today
Sept 11, 2024 18:22 HKT/SGT
|
|
|
Moody's Reaffirms GTJAI's 'Baa2' Long-term Issuer Rating with a 'Stable' Outlook
Sept 11, 2024 17:28 HKT/SGT
|
|
|
國泰君安國際獲穆迪重申“Baa2” 長期發行人評級，展望“穩定”
Sept 11, 2024 17:12 HKT/SGT
|
|
|
国泰君安国际获穆迪重申“Baa2” 长期发行人评级，展望“稳定”
Sept 11, 2024 17:06 HKT/SGT
|
|
|
Honda Begins Joint Research on AI Technologies with the Indian Institutes of Technology in Delhi and Bombay to Further Advance Honda CI (Cooperative Intelligence)
Sept 11, 2024 16:10 JST
|
|
|
MHI-MS、駐車場などでの自動バレーパーキング、完成車自動搬送向け事業展開を加速
Sept 11, 2024 14:30: JST
|
|
|
Honda、協調人工知能Honda CIのさらなる進化を目指し、インド工科大学デリー校およびボンベイ校とAI技術の共同研究を開始
Sept 11, 2024 14:30: JST
|
|
|
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱（HTD1801）在T2DM中的两项事后分析
Sept 11, 2024 11:51 HKT/SGT
|
|
|
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies
Sept 11, 2024 11:34 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
